Skip to main content

Aspirin may reduce the risk of dying from cancer, research shows

When British researchers looked at eight trials in which more than 25,000 patients participated, they learned that two decades later, the risk of those patients dying from lung cancer fell 30%, the risk of dying from esophageal cancer decreased by 60%, and the risk of dying from colorectal cancer dropped 40%, according to U.S. News and World Report.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino